SEC Form 4 · accession 0000899243-19-003198
COVETRUS, INC. · CVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Paladino
Director
Period of report
Feb 7, 2019
Accepted (ET)
Feb 11, 2019 · 6:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001752836
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 7, 2019 | A | 36,749 | — | A | 36,749 | D | |
| Common StockF1 | Feb 7, 2019 | A | 2,673 | — | A | 2,673 | I | By 401(k) plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Received in the pro rata distribution of shares of common stock of Covetrus, Inc. ("Covetrus") owned by Henry Schein, Inc. ("Henry Schein") to the stockholders of Henry Schein in connection with the spin-off of the Henry Schein Animal Health Business into Covetrus, pursuant to the Contribution and Distribution Agreement, dated as of April 20, 2018, by and among Henry Schein, Covetrus, Direct Vet Marketing, Inc. (d/b/a Vets First Choice) ("Vets First Choice"), and Shareholder Representative Services LLC, solely in its capacity as the representative of the Vets First Choice stockholders and for the purposes of certain articles set forth therein, as amended.